Nitric Oxide and Salt Resistance in Dahl Rats: No Role of Inducible NO Synthase

被引:2
|
作者
Zicha, Josef [1 ]
Rezacova, Lenka [1 ]
Vaneckova, Ivana [1 ]
机构
[1] Czech Acad Sci, Lab Expt Hypertens, Inst Physiol, Videnska 1083, Prague 14200 4, Czech Republic
关键词
High salt intake; Dahl salt-resistant rats; Blood pressure; NO synthase II; Aminoguanidine; AMT; Renin-angiotensin system; Sympathetic nervous system; Nitric oxide; SYMPATHETIC-NERVOUS-SYSTEM; BLOOD-PRESSURE; SENSITIVE HYPERTENSION;
D O I
10.33549/physiolres.935047
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Inducible NO synthase (NOS II) was proposed to play an important role in salt resistance of Dahl salt-resistant (SR/Jr) rats. Its chronic inhibition by specific inhibitors was accompanied by blood pressure (BP) elevation in animals subjected to high salt intake. The aim of our study was to evaluate 1) whether such inhibitors affect BP and/or its particular components (sympathetic tone and NO-dependent vasodilation) only under the conditions of high salt intake, and 2) whether similar BP effects are elicited after systemic or intracerebroventricular (icv) application of these inhibitors. Wistar rats fed Altromin diet (0.45 % NaCl) and SR/Jr rats fed either a low-salt (LS, 0.3 % NaCl) or a high-salt (HS, 4 % NaCl) diet were studied. Aminoguanidine (AMG) and 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT) were used as NOS II inhibitors. BP and its responses to acute blockade of renin-angiotensin system (captopril), sympathetic nervous system (pentolinium) and NO synthase (L-NAME) were measured in conscious cannulated rats. There were no significant changes of BP or its components in either Wistar rats or SR/Jr rats subjected to chronic inhibition of NOS II by peroral aminoguanidine administration (50 mg/kg/day for 4 weeks). This was true for SR/Jr rats fed either LS or HS diets. Furthermore, we have studied BP effects of chronic icv administration of both NOS II inhibitors in SR/Jr rats fed HS diet, but we failed to find any BP changes elicited by such treatment. In conclusion, inducible NO synthase does not participate in the resistance of SR/Jr rats to hypertensive effects of excess salt intake.
引用
收藏
页码:123 / 127
页数:5
相关论文
共 50 条
  • [1] Nitric Oxide and Salt Resistance in Dahl Rats: No Role of Inducible NO Synthase (vol 72, pg 123, 2023)
    Zicha, Josef
    Rezacova, Lenka
    Vaneckova, Ivana
    PHYSIOLOGICAL RESEARCH, 2023, 72 (05) : 682 - 682
  • [2] The role of renal medullary inducible nitric oxide synthase in Dahl salt-sensitive hypertension
    Tian, N
    Gannon, AW
    Payne, JA
    Khalil, RA
    Manning, RD
    FASEB JOURNAL, 2003, 17 (04): : A488 - A489
  • [3] Role of inducible nitric oxide synthase (iNOS) in Dahl salt-sensitive hypertension.
    Tan, DY
    O'Bryan, TM
    Polk, HM
    Manning, RD
    FASEB JOURNAL, 1998, 12 (04): : A98 - A98
  • [4] Modulation of renal nitric oxide synthase isoforms by salt in Dahl rats
    Rudd, MA
    Anand, S
    Daumerie, G
    Toolan, G
    Tam, B
    Trolliet, MR
    Loscalzo, J
    CIRCULATION, 1999, 100 (18) : 534 - 534
  • [5] Inhibition of inducible nitric oxide synthase (iNOS) causes salt sensitive hypertension in Dahl salt-resistant rats.
    Manning, RD
    Tan, DY
    Meng, S
    Cason, GW
    FASEB JOURNAL, 1999, 13 (05): : A781 - A781
  • [6] Expression of inducible nitric oxide synthase, left ventricular function and remodeling in Dahl salt-sensitive hypertensive rats
    Horinaka, S
    Kobayashi, N
    Mori, Y
    Yagi, H
    Onoda, M
    Matsuoka, H
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 91 (01) : 25 - 35
  • [7] Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension
    Tan, DY
    Meng, SM
    Manning, RD
    HYPERTENSION, 1999, 33 (01) : 456 - 461
  • [9] Role of neuronal nitric oxide synthase and inducible nitric oxide synthase in intestinal injury in neonatal rats
    Lu, Hui
    Zhu, Bing
    Xue, Xin-Dong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (27) : 4364 - 4368
  • [10] Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats
    Ni, ZM
    Oveisi, F
    Vaziri, ND
    HYPERTENSION, 1999, 34 (04) : 552 - 557